| Vandetanib studied in …STUDIED_INderived99 of 99show fewer |
|---|
| → studied in | NCT01582191Phase 1 · completed Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer · 99 trials list this drug (3 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01298323Phase 3 · completed Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment · 99 trials list this drug (3 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04211337Phase 3 · active not recruiting A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer · 99 trials list this drug (3 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01496313Phase 4 · completed To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer · 99 trials list this drug (3 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00410761Phase 3 · completed An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer · 99 trials list this drug (3 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01601808Phase 2 · completed Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma · 99 trials list this drug (3 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02299999Phase 2 · active not recruiting SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer · 99 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00418886Phase 3 · completed Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients · 99 trials list this drug (3 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01945762completed Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer · 99 trials list this drug (3 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06482086Phase 2 · recruiting Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer · 99 trials list this drug (3 active) | — | — | Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01876784Phase 3 · completed Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer · 99 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00537095Phase 2 · completed Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer · 99 trials list this drug (3 active) | — | — | Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02117167Phase 2 · completed SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients · 99 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04760288Phase 3 · withdrawn A Study of Pralsetinib Versus Standard of Care (SOC) for Treatment of RET-Mutated Medullary Thyroid Cancer (MTC). · 99 trials list this drug (3 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01934335Phase 2 · terminated Effect of Vandetanib on Cellular Markers in Invasive Breast Cancer · 99 trials list this drug (3 active) | — | — | Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03630120Phase 2 · terminated Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer · 99 trials list this drug (3 active) | — | — | Thyroid Gland Follicular Carcinoma,Malignant Thyroid Gland Neoplasm,Thyroid Gland Medullary Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02495103Phase 1/Phase 2 · terminated Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma · 99 trials list this drug (3 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01183559Phase 1 · completed A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery · 99 trials list this drug (3 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01414426Phase 2 · completed Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions · 99 trials list this drug (3 active) | — | — | Lip and Oral Cavity Squamous Cell Carcinoma,Oral Cavity Verrucous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00514046Phase 1/Phase 2 · completed Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer · 99 trials list this drug (3 active) | — | — | Multiple Endocrine Neoplasia Type 2A,Multiple Endocrine Neoplasia Type 2B,Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01823068Phase 2 · completed Vandetanib in Advanced NSCLC With RET Rearrangement · 99 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02239952NA · unknown HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors) · 99 trials list this drug (3 active) | — | — | Malignant Neoplasm,High-Grade Glioma, NOS | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02015065Phase 2 · completed Phase II Trial of Vandetanib in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors · 99 trials list this drug (3 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02638428Phase 2 · unknown Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy · 99 trials list this drug (3 active) | — | — | Childhood Solid Neoplasm,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00613626Phase 2 · completed Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer · 99 trials list this drug (3 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00272350Phase 1 · completed ZD6474 to Treat Advanced Brain Cancer in Patients · 99 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01191892Phase 2 · completed Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer · 99 trials list this drug (3 active) | — | — | Malignant Bladder Neoplasm,Malignant Ureter Neoplasm,Malignant Urethral Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00459121Phase 2 · terminated Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery · 99 trials list this drug (3 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00441142Phase 1/Phase 2 · completed Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors · 99 trials list this drug (3 active) | — | — | Glioblastoma,Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00923247Phase 1/Phase 2 · terminated A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC) · 99 trials list this drug (3 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00745732Phase 1 · terminated Radiation Therapy (XRT) and ZD6474 in Non-Small Cell Lung Cancer (NSCLC) · 99 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00566995Phase 2 · completed Phase II Study of Vandetanib in Individuals With Kidney Cancer · 99 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00880334Phase 2 · completed Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC · 99 trials list this drug (3 active) | — | — | Transitional Cell Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098345Phase 2 · completed Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer · 99 trials list this drug (3 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00364351Phase 3 · completed Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy · 99 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00500292Phase 2 · completed A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer · 99 trials list this drug (3 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01539655Phase 1 · completed Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib · 99 trials list this drug (3 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02109250completed CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice · 99 trials list this drug (3 active) | — | — | Thyroid Gland Medullary Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00937417Phase 1 · withdrawn S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors · 99 trials list this drug (3 active) | — | — | Adult Solid Neoplasm,Malignant Breast Neoplasm,Malignant Head and Neck Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00481845Phase 2 · terminated Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer · 99 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00358956Phase 2 · completed A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer · 99 trials list this drug (3 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00686036Phase 2 · terminated Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapy · 99 trials list this drug (3 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00872989Phase 2 · completed S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer · 99 trials list this drug (3 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00659438Phase 2 · completed Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate Cancer · 99 trials list this drug (3 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00752986Phase 2 · terminated ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex Trial · 99 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01661179Phase 1/Phase 2 · completed Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Carcinoma · 99 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00753714Phase 2 · completed Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine · 99 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00508001Phase 2 · completed Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC) · 99 trials list this drug (3 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00597116Phase 2 · terminated An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma · 99 trials list this drug (3 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00753675Phase 2 · completed Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer · 99 trials list this drug (3 active) | — | — | Malignant Biliary Tract Neoplasm,Malignant Gallbladder Neoplasm,Malignant Extrahepatic Bile Duct Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00777179Phase 2 · completed Phase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet Chemotherapy · 99 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00862836Phase 1/Phase 2 · terminated Addition of Vandetanib to Standard Therapy Pegliposomal Doxorubicin (PLD) · 99 trials list this drug (3 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454116Phase 2 · completed A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients · 99 trials list this drug (3 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00498797Phase 2 · completed E3-Hormone Refractory Prostrate Cancer Taxotere Combination · 99 trials list this drug (3 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00312377Phase 3 · completed ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer · 99 trials list this drug (3 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00404924Phase 3 · completed ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures · 99 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00494481Phase 2 · completed E3 Breast Cancer Taxotere Combination · 99 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00503711Phase 1 · completed Phase I Chinese PK · 99 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02013089NA · unknown A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study · 99 trials list this drug (3 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00450138Phase 1 · completed Open Label, Phase I ZD6474 Head and Neck Cancer Study · 99 trials list this drug (3 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00681798Phase 1 · completed Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma · 99 trials list this drug (3 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00807170Phase 1 · terminated Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain Metastases · 99 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00496275Phase 1 · completed Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC · 99 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00496509Phase 1 · completed Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer · 99 trials list this drug (3 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047840Phase 2 · completed This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer. · 99 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00071188Phase 2 · completed ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) · 99 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00252746Phase 2 · completed ZD6474 Phase IIa Dose Finding Multicentre Study · 99 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00499850Phase 1 · completed Phase I FOLFOX Combination · 99 trials list this drug (3 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00506051Phase 1 · completed ZD6474(Vandetanib) + Alimta Combo Study · 99 trials list this drug (3 active) | — | — | Carcinoma,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00507091Phase 1 · completed Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination · 99 trials list this drug (3 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00034918Phase 2 · completed This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer · 99 trials list this drug (3 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047788Phase 2 · completed Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer · 99 trials list this drug (3 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00059722Phase 2 · completed This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC. · 99 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00066313Phase 2 · completed ZD6474 in Treating Patients With Small Cell Lung Cancer · 99 trials list this drug (3 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00290537Phase 2 · terminated Phase II Study of ZD6474 in Advanced NSCLC · 99 trials list this drug (3 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00995007Phase 2 · completed A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas · 99 trials list this drug (3 active) | — | — | Anaplastic Astrocytoma,Anaplastic Oligodendroglioma,Glioblastoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00402896Phase 2 · terminated Malignant Pleural Effusion With ZD6474 · 99 trials list this drug (3 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01941849Phase 1 · withdrawn Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma · 99 trials list this drug (3 active) | — | — | Paraganglioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720083Phase 2 · terminated Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer · 99 trials list this drug (3 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01372813Phase 2 · terminated Vandetanib to Treat Advanced Kidney Cancer · 99 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01004419Phase 1 · withdrawn Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer · 99 trials list this drug (3 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02530411Phase 2 · unknown Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer · 99 trials list this drug (3 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00821080Phase 1 · completed Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma · 99 trials list this drug (3 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00410189Phase 2 · completed BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC · 99 trials list this drug (3 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00683787Phase 2 · terminated Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer · 99 trials list this drug (3 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00601614Phase 1 · withdrawn Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery · 99 trials list this drug (3 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00660725Phase 1 · completed Study of GemOx and Vandetanib in Advanced Solid Malignancy · 99 trials list this drug (3 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00551096Phase 1 · completed Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors · 99 trials list this drug (3 active) | — | — | Malignant Solid Neoplasm,Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00496665Phase 1 · completed ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer · 99 trials list this drug (3 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00459043Phase 2 · completed Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck · 99 trials list this drug (3 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00822887Phase 1 · completed Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas · 99 trials list this drug (3 active) | — | — | Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00757692Phase 2 · completed Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer. · 99 trials list this drug (3 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00472017Phase 1 · completed Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma · 99 trials list this drug (3 active) | — | — | Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00436072Phase 1 · completed ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer · 99 trials list this drug (3 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00532909Phase 1 · completed Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer · 99 trials list this drug (3 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445549Phase 2 · terminated Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · 99 trials list this drug (3 active) | — | — | Peritoneal Neoplasm,Fallopian Tube Neoplasm,Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00734890Phase 1 · completed Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma · 99 trials list this drug (3 active) | — | — | Adult Solid Neoplasm,Lymphoma,Malignant Lung Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00533169Phase 1 · terminated ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma · 99 trials list this drug (3 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00732745Phase 1 · terminated Vandetanib, Oxaliplatin, and Docetaxel in Advanced Cancer of the Esophagus or Gastroesophageal Junction · 99 trials list this drug (3 active) | — | — | Malignant Esophageal Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |